日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD4(+) T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.

CD4(+) T 细胞介导 BCMA CAR-T 细胞治疗后 CAR-T 细胞相关的免疫相关不良事件。

Ho Matthew, Paruzzo Luca, Noll Julia Han, Stella Federico, Devi Pooja, Ndeupen Sonia, Day Yael A, Chen Gregory M, Cohen Ivan J, Ramirez-Fernandez Angel, Waxman Adam, Kapur Shivani, Chen Fang, Xu Rong, Huff Andrew, Jarocha Danuta, Patel Vrutti, Bochi-Layec Audrey C, Ramasubramanian Ranjani, Liu Shan, Bouvier Riemke, de Souza Vitor B, Patel Heta, Li Ziyu, Carturan Alberto, Michener Peter, Hopkins Caitlin R, Koucky Owen, Minehart Janna, Dimitri Alex, Nabar Neel R, Hasanali Zainul S, Ciccarelli Bryan T, Hung Putzer, Williams Erik, Bartoszek Robert, Lavorando Maya, Mohan Suyash, Gonzalez Vanessa E, Porazzi Patrizia, Bhoj Vijay G, Apostolidis Sokratis A, Vogl Dan T, Porter David L, Scholler John, Diorio Caroline, Roche Aoife M, Everett John K, Bushman Frederic D, Nathanson Katherine L, Stadtmauer Edward A, Susanibar-Adaniya Sandra P, Garfall Alfred L, Ruella Marco, Cohen Adam D, Fraietta Joseph A

Role of the anti-Shine-Dalgarno sequence of 16S rRNA in Flavobacterium johnsoniae

黄杆菌16S rRNA中抗Shine-Dalgarno序列的作用

Naeem, Fawwaz M; Roy, Bappaditya; Arpin, Dominic; McNutt, Zakkary A; Moon, Kyung-Mee; Gemler, Bryan T; Bundschuh, Ralf; Foster, Leonard J; Ortega, Joaquin; Fredrick, Kurt

Ultrasound-guided nanocomposite hydrogel injection to enhance nerve repair via temporal delivery of a colony-stimulating factor 1 receptor inhibitor

超声引导下纳米复合水凝胶注射,通过暂时性递送集落刺激因子1受体抑制剂来增强神经修复。

He, Zhi; Alimi, Olawale A; Pan, Tianshu; Kuss, Mitchell; Hackfort, Bryan T; Krishnan, Mena A; Li, Yiran; Liu, Bo; Duan, Bin

Toward AI foundation models for epidemics: Promise, challenges, and paths forward

迈向人工智能基础模型在流行病学中的应用:前景、挑战与未来路径

Lau, Max S Y; Metcalf, C Jessica E; Liu, Zewen; Grenfell, Bryan T; Jin, Wei

Senolytic-Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers.

抗衰老细胞具有独特的 SASP 特征和功能影响:开发衰老增敏剂的途径。

Tripathi Utkarsh, Suda Masayoshi, Kulshreshtha Vagisha, Piatkowski Bryan T, Palmer Allyson K, Giorgadze Nino, Inman Christina, Gasek Nathan, Xu Ming, Johnson Kurt O, Pirtskhalava Tamar, Chaib Selim, Langhi Prata Larissa P G, Zhu Yi, Kandhaya-Pillai Renuka, Tullius Stefan G, Wyles Saranya P, Majji Rambabu, Yalamanchili Hari Krishna, Allison David B, Tchkonia Tamar, Kirkland James L

Genomic signatures in Variovorax enabling colonization of the Populus endosphere

Variovorax 的基因组特征使其能够定殖于杨树内生层。

Beals, Delaney G; Carper, Dana L; Hochanadel, Leah H; Jawdy, Sara S; Klingeman, Dawn M; Piatkowski, Bryan T; Weston, David J; Doktycz, Mitchel J; Pelletier, Dale A

A pipeline of machine learning-driven multi-modal data fusion methods for prognostic risk analysis in bevacizumab-treated metastatic colorectal cancer

基于机器学习的多模态数据融合方法在贝伐珠单抗治疗的转移性结直肠癌预后风险分析中的应用

Thomas, Valentina; Nyamundanda, Gift; Lärkeryd, Adrian; Hari, P S; Miller, Ian S; Venken, Tom; Smeets, Dominiek; Boeckx, Bram; Betge, Johannes; Ebert, Matthias P A; Gaiser, Timo; Murphy, Verena; Kay, Elaine; Verheul, Henk M; O'Farrell, Alice C; Cremolini, Chiara; Marmorino, Federica; Gallagher, William M; Barat, Ana; Klinger, Rut; Fender, Bozena; Ylstra, Bauke; van Grieken, Nicole; McNamara, Deborah A; Hennessy, Bryan T; Das, Sudipto; Moran, Bruce; O'Connor, Darran P; Dienstmann, Rodrigo; Lambrechts, Diether; Prehn, Jochen H M; Sadanandam, Anguraj; Byrne, Annette T

Emergence of Dalbavancin, Vancomycin, and Daptomycin Cross-resistance in MRSA During Long-term LVAD Suppression With Vancomycin Followed by Dalbavancin: Genomic Insights and Synergy With Cefadroxil

在长期使用万古霉素抑制左心室辅助装置(LVAD)治疗期间,MRSA 出现达巴万星、万古霉素和达托霉素交叉耐药性,随后使用达巴万星:基因组学见解及与头孢羟氨苄的协同作用

Stohs, Erica J; Alexander, Bryan T; Fey, Paul D; Foreman, Melanie C L; Xu, Libin; Penewit, Kelsi; Waalkes, Adam; Salipante, Stephen J; Werth, Brian J

Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemcitabine and NAB-paclitaxel therapy in advanced pancreatic cancer

NCT04617067 是一项 II 期、开放标签的临床试验,旨在评估口服帕立骨化醇联合吉西他滨和 NAB-紫杉醇疗法治疗晚期胰腺癌的疗效,该试验已提前终止。

Easty, David; McDermott, Ray; Murphy, Adrian G; Grogan, Liam; Morris, Patrick G; Breathnach, Oscar S; Egan, Keith; Toomey, Sinead; Horgan, Anne; Power, Derek; Osman, Nemer; Parker, Imelda; Donachie, Vicky; Shevlin, Anna; Barrett, Aisling; Nolan, Marc; Marron, Jacinta; Farr, Christine J; Hennessy, Bryan T

Case Report: Whole-genome sequencing of urothelial carcinoma in an adult patient with CLOVES syndrome reveals a lack of PIK3CA mutation and a genomic landscape consistent with urothelial carcinoma

病例报告:对一名患有CLOVES综合征的成年患者的尿路上皮癌进行全基因组测序,结果显示缺乏PIK3CA突变,且基因组图谱与尿路上皮癌一致。

McAuley, Lauren; Fitzpatrick, Orla; Cosgrove, Nicola; Yacoub, Jad; Grogan, Liam; Hennessy, Bryan T; Furney, Simon J; Toomey, Sinead